SCHEMBL7403729

SCHEMBL7403729

COc1ccc(N2CCN(CCC3OCCc4cc(Br)ccc43)CC2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 10/20 0.74
HTR1D P28221 8/20 0.74
HTR2A P28223 7/20 0.74
DRD4 P21917 6/20 0.74
HTR1A P08908 5/20 0.74
HTR1B P28222 1/20 0.70
ADRA2A P08913 1/20 0.55
ADRA2B P18089 1/20 0.55
ADRA2C P18825 1/20 0.55
DRD1 P21728 1/20 0.55
ADRA1D P25100 1/20 0.55
ADRA1A P35348 1/20 0.55
ADRA1B P35368 1/20 0.55
DRD3 P35462 1/20 0.55
HTR2B P41595 1/20 0.55
SLC6A4 P31645 1/20 0.51
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA4 P22748 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8591943 1.00 DRD2 (0.74) DRD2HTR1DHTR2ADRD4HTR1A
SCHEMBL8590932 1.00 DRD2 (0.74) DRD2HTR1DHTR2ADRD4HTR1A
Hydrochloric Acid SCHEMBL7403803 0.99 DRD2 (0.73) DRD2HTR1DHTR2ADRD4HTR1A
SCHEMBL7399582 0.92 DRD2 (0.74) DRD2HTR1DHTR2ADRD4HTR1A
SCHEMBL8591186 0.90 DRD2 (0.61) DRD2HTR1DHTR2ADRD4HTR1A
SCHEMBL8591632 0.90 DRD2 (0.61) DRD2HTR1DHTR2ADRD4HTR1A
SCHEMBL8591181 0.90 DRD2 (0.61) DRD2HTR1DHTR2ADRD4HTR1A
SCHEMBL8642441 0.90 DRD2 (0.77) DRD2HTR1DHTR2ADRD4HTR1A
SCHEMBL7401718 0.89 DRD2 (0.76) DRD2HTR1DHTR2ADRD4HTR1A
SCHEMBL7398929 0.89 DRD2 (0.58) DRD2HTR1DHTR2ADRD4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
US-5877317-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 1999-03-02 US disclosed
EP-0836599-A1 1,6-DISUBSTITUTED ISOCHROMANS FOR TREATMENT OF MIGRAINE HEADACHES PHARMACIA & UPJOHN COMPANY (US) 1998-04-22 EP disclosed
WO-1997002259-A1 1,6-DISUBSTITUTED ISOCHROMANS FOR TREATMENT OF MIGRAINE HEADACHES PHARMACIA & UPJOHN COMPANY (US) 1997-01-23 WO disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed